article_metadata: N M van der Veen J F G M Brouns J P Doornbos W J van Wijngaarden
article_metadata: 10.1007/s00404-010-1561-7
article_metadata: Arch Gynecol Obstet
article_metadata: 2011 Jan;283(1):1-5.
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/20593191/
article_metadata: Abortifacient Agents, Nonsteroidal / adverse effects Abortion, Induced / adverse effects Misoprostol / adverse effects Ultrasonography, Prenatal Uterine Rupture / chemically induced Uterus / abnormalities Uterus / diagnostic imaging
article_metadata: Abortifacient Agents, Nonsteroidal / adverse effects Abortion, Induced / adverse effects Misoprostol / adverse effects Ultrasonography, Prenatal Uterine Rupture / chemically induced Uterus / abnormalities Uterus / diagnostic imaging Case Reports Review Abortifacient Agents, Nonsteroidal / administration & dosage Adult Female Humans Misoprostol / administration & dosage Pregnancy Pregnancy Trimester, First / drug effects Risk Treatment Outcome Uterine Rupture / diagnostic imaging Uterine Rupture / epidemiology Abortifacient Agents, Nonsteroidal Misoprostol
article_metadata: PMC3015193
article_metadata: 20593191
article_metadata: Misoprostol and termination of pregnancy: is there a need for ultrasound screening in a general population to assess the risk for adverse outcome in cases of uterine anomaly?
article_metadata: 2011